Drug-Radiotherapy Combination Trial Developments-Response
Clin Cancer Res
.
2021 Jan 1;27(1):356.
doi: 10.1158/1078-0432.CCR-20-4163.
Authors
Eric Deutsch
1
2
,
Cyrus Chargari
3
2
4
,
Ralph R Weichselbaum
5
,
Antonin Levy
1
2
Affiliations
1
Department of Radiation Oncology, Gustave Roussy, Villejuif, France. antonin.levy@gustaveroussy.fr eric.deutsch@gustaveroussy.fr.
2
Université Paris-Saclay, INSERM U1030, Radiothérapie Moléculaire, Villejuif, France.
3
Department of Radiation Oncology, Gustave Roussy, Villejuif, France.
4
Institut de Recherche Biomédicale des Armées, Brétigny sur Orge, France.
5
Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois.
PMID:
33397680
DOI:
10.1158/1078-0432.CCR-20-4163
No abstract available
Publication types
Letter
Comment
MeSH terms
Carcinoma, Non-Small-Cell Lung*
Humans
Lung Neoplasms*
Pharmaceutical Preparations*
Radiation Oncology*
Substances
Pharmaceutical Preparations